JSPR (Jasper Therapeutics, Inc. Common Stock) Stock Analysis - Hedge Fund Holdings
Jasper Therapeutics, Inc. Common Stock (JSPR) is a publicly traded Healthcare sector company. As of May 21, 2026, JSPR trades at $0.89 with a market cap of $22.58M and a P/E ratio of -0.22. JSPR moved +0.00% today. Year to date, JSPR is -52.33%; over the trailing twelve months it is -82.69%. Its 52-week range spans $0.62 to $26.05. Analyst consensus is buy with an average price target of $7.88. Rallies surfaces JSPR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Who owns JSPR stock?
Hedge funds tracked by Rallies that own JSPR include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Jasper Therapeutics, Inc. Common Stock.
JSPR Key Metrics
Key financial metrics for JSPR
Metric
Value
Price
$0.89
Market Cap
$22.58M
P/E Ratio
-0.22
EPS
$-3.95
Dividend Yield
0.00%
52-Week High
$26.05
52-Week Low
$0.62
Volume
328
Avg Volume
0
Revenue (TTM)
$0
Net Income
$-75.80M
Gross Margin
0.00%
Top Hedge Funds Holding JSPR
Panagora Asset holds 21.54K shares of JSPR, changed +11.26% as of Mar 31, 2026.
Hedge funds tracked by Rallies that own JSPR include Panagora Asset. The latest tracked quarter is Mar 31, 2026. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Jasper Therapeutics, Inc. Common Stock.
Does Rallies show 13F holders for JSPR?
Yes. Rallies tracks hedge fund and 13F ownership data for JSPR, including fund names, share counts, latest tracked quarter, and position changes when available.
Is JSPR research on Rallies investment advice?
No. Rallies provides research, data, and educational context for JSPR. It does not provide personalized investment advice.